Interestingly, the high levels of the thymus tissue regenerative cytokine IL-22 [14] produced by ThCD103 cells were markedly reduced in MG patients previously treated with thymectomy (Fig. 4g, Supplementary Fig. 6b). The gene discussed is IL22; the disease is myasthenia gravis.